KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInvested CapitalNet Margin

National Health Investors (NHI) Return on Sales (2016 - 2020)

National Health Investors (NHI) has disclosed Return on Sales for 12 consecutive years, with 0.08% as the latest value for Q2 2020.

  • For the quarter ending Q2 2020, Return on Sales fell 25.0% year-over-year to 0.08%, compared with a TTM value of 0.08% through Jun 2020, down 17.0%, and an annual FY2019 reading of 0.51%, down 2.0% over the prior year.
  • Return on Sales was 0.08% for Q2 2020 at National Health Investors, down from 0.17% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.54% in Q4 2016 and bottomed at 0.08% in Q2 2020.
  • Average Return on Sales over 5 years is 0.34%, with a median of 0.34% recorded in 2017.
  • The sharpest move saw Return on Sales decreased -26bps in 2016, then rose 8bps in 2017.
  • Year by year, Return on Sales stood at 0.54% in 2016, then plummeted by -49bps to 0.27% in 2017, then increased by 1bps to 0.28% in 2018, then decreased by -13bps to 0.24% in 2019, then crashed by -65bps to 0.08% in 2020.
  • Business Quant data shows Return on Sales for NHI at 0.08% in Q2 2020, 0.17% in Q1 2020, and 0.24% in Q4 2019.